(HealthDay News) — More community hospitals are giving tissue plasminogen activator (tPA) medication to stroke victims, improving their chances of survival and recovery, new research indicates. The ...

Previously, the guidelines said the drug must be delivered within three hours of the onset of symptoms. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive ...

November 18, 2010 — About half of stroke patients cannot communicate their body weight (BW), only 1 in 5 relatives are able to provide this information, and a physician's or nurse's visual estimation ...

A new analysis suggests that about a quarter of potentially eligible patients are not receiving thrombolysis for ischemic stroke, and some of the reasons for this might be modifiable, researchers say.

(HealthDay News) — Endovascular therapy with mechanical thrombectomy in ischemic stroke is superior to standard treatment with tissue plasminogen activator (tPA) for preserving brain function, ...

Adult patients with sickle cell disease who experience a stroke caused by a clot (i.e., ischemic strokes) can be treated safely with tissue plasminogen activator if they qualify, report investigators.

A study of patients with ischemic stroke suggests that many of those who receive prompt hospital treatment with "clot-busting" tissue plasminogen activator (tPA) therapy can avoid lengthy, restrictive ...

Adult patients with sickle cell disease (SCD) who experience a stroke caused by a clot (i.e., ischemic strokes or IS) can be treated safely with tissue plasminogen activator (tPA) if they qualify, ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Treatment of stroke with tissue plasminogen activator within 4.5 hours of stroke onset reduces ...

Ischemic stroke, caused by a clot in a blood vessel that cuts off blood flow to the brain, is the most common form of stroke and the second leading cause of death for those over 60. In the United ...